Profile
Andrew H.
Chang worked as a Director of Investor Relations at Astellas Gene Therapies, Inc. and later as the Head of Investor Relations and Corporate Communication at Applied Molecular Transport, Inc. from 2020 to 2023.
Former positions of Andrew H. Chang
Companies | Position | End |
---|---|---|
APPLIED MOLECULAR TRANSPORT INC. | Investor Relations Contact | 27/12/2023 |
AUDENTES THERAPEUTICS, INC. | Investor Relations Contact | 01/01/2020 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
Private companies | 1 |
---|---|
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Andrew H. Chang